Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Metreleptin in Type 1 Diabetes Mellitus

This study has been terminated.
(Sponsor request)
Juvenile Diabetes Research Foundation
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
Abhimanyu Garg, University of Texas Southwestern Medical Center Identifier:
First received: December 29, 2010
Last updated: May 2, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2014
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)